Syntheses and cytotoxicity of phosphatidylcholines containing ibuprofen or naproxen moieties

Sci Rep. 2019 Jan 18;9(1):220. doi: 10.1038/s41598-018-36571-1.

Abstract

In this study, novel phosphatidylcholines containing ibuprofen or naproxen moieties were synthesized in good yields and high purities. Under the given synthesis conditions, the attached drug moieties racemized, which resulted in the formation of phospholipid diastereomers. The comperative studies of the cytotoxicity of ibuprofen, naproxen and their phosphatidylcholine derivatives against human promyelocytic leukemia HL-60, human colon carcinoma Caco-2, and porcine epithelial intestinal IPEC-J2 cells were carried out. The results of these studies indicated that phospholipids with NSAIDs at both sn-1 and sn-2 positions (15 and 16) were more toxic than ibuprofen or naproxen themselves, whereas 2-lysophosphatidylcholines (7 and 8) were less toxic against all tested cell lines. Phospholipids with NSAIDs at sn-1 and palmitic acid at sn-2 (9 and 10) were also less toxic against Caco-2 and normal cells (IPEC-J2).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal
  • Caco-2 Cells
  • Cell Line
  • Cytotoxins / toxicity
  • Epithelial Cells
  • Humans
  • Ibuprofen / chemistry*
  • Lysophosphatidylcholines
  • Naproxen / chemistry*
  • Palmitic Acid
  • Phosphatidylcholines / chemical synthesis*
  • Phosphatidylcholines / toxicity*
  • Phospholipids
  • Swine

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytotoxins
  • Lysophosphatidylcholines
  • Phosphatidylcholines
  • Phospholipids
  • Palmitic Acid
  • Naproxen
  • Ibuprofen